Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes Paolo PalmiscianoTarek Y. El AhmadiehRaymond Sawaya Topic Review 19 November 2021 Pages: 215 - 224
H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients Huy Gia VuongHieu Trong LeIan F. Dunn Topic Review 18 November 2021 Pages: 225 - 234
Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy Tokunori KanazawaKentaro OharaHikaru Sasaki Laboratory Investigation 31 October 2021 Pages: 235 - 246
Increased proliferation is associated with CNS invasion in meningiomas Felix BehlingChristina FodiMarco Skardelly Laboratory Investigation Open access 20 November 2021 Pages: 247 - 254
Surgical strategies for older patients with glioblastoma Tanyeri BarakShaurey VetsaJennifer Moliterno Clinical Study Open access 09 October 2021 Pages: 255 - 264
Correction to: Surgical strategies for older patients with glioblastoma Tanyeri BarakShaurey VetsaJennifer Moliterno Correction Open access 23 November 2021 Pages: 265 - 265
Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant Beomseok SohnChansik AnSeung-Koo Lee Clinical Study Open access 14 October 2021 Pages: 267 - 276
Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation Jessica A. WilcoxSamantha BrownNelson S. Moss Clinical Study 16 October 2021 Pages: 277 - 286
Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study Antoine GirardPierre-Jean Le ResteFlorence Le Jeune Clinical Study 22 October 2021 Pages: 287 - 295
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas Karan S DixitSean SachdevJeffrey J Raizer Clinical Study 24 October 2021 Pages: 297 - 306
Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial Frank SaranLiam WelshMichael Brada Clinical Study Open access 17 November 2021 Pages: 307 - 317
Mitochondrial DNA sequence variation and risk of meningioma Claudine M. SamanicJamie K. TeerKathleen M. Egan Clinical Study 20 October 2021 Pages: 319 - 324
The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery Nicolin HaincNoor AlsafwaniPaula Alcaide-Leon Clinical Study Open access 24 October 2021 Pages: 325 - 333
The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience Hirotaka HasegawaKunal VakhariaBruce E. Pollock Clinical Study 27 October 2021 Pages: 335 - 342
Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study Adomas BuneviciusStylianos PikisJason Sheehan Clinical Study 19 November 2021 Pages: 343 - 351
Residential distance from the reporting hospital and survival among adolescents, and young adults diagnosed with CNS tumors Kimberly J. JohnsonXiaoyan WangArash Delavar Clinical Study 12 November 2021 Pages: 353 - 361
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 Nirav PatilEashwar SomasundaramJill S. Barnholtz-Sloan Clinical Study Open access 10 November 2021 Pages: 363 - 372
Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2 Shi-wei LiJing ZhangPi-nan Liu Clinical Study 09 November 2021 Pages: 373 - 381
Is H3 K27M mutation testing relevant in the diagnostic routine of WHO grade 4 gliomas exclusively located in the corpus callosum in adults? Charlotte PaoliStephane SegardFanny Burel-Vandenbos Letter to the Editor 20 November 2021 Pages: 383 - 384